SCHEMBL23787676

SCHEMBL23787676

CCc1cc(-c2ccc(/N=N/c3cc(S(=O)(=O)O)c4ccccc4c3O)c(CC)c2)ccc1/N=N/c1cc(S(=O)(=O)O)c2ccccc2c1O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.52
▸ THRB P10828 3/20 0.52
▸ APP P05067 3/20 0.52
▸ MAPT P10636 3/20 0.52
▸ SNCA P37840 3/20 0.52
▸ HPGD P15428 3/20 0.52
▸ MEN1 O00255 2/20 0.52
▸ ALDH1A1 P00352 2/20 0.52
▸ RECQL P46063 2/20 0.52
▸ BLM P54132 2/20 0.52
▸ KMT2A Q03164 2/20 0.52
▸ ALOX12 P18054 1/20 0.52
▸ TDP1 Q9NUW8 1/20 0.52
▸ PHLPP2 Q6ZVD8 2/20 0.52
▸ MPL P40238 3/20 0.49
▸ CTRC Q99895 1/20 0.49
▸ CTRB1 P17538 1/20 0.48
▸ SENP2 Q9HC62 4/20 0.46
▸ SENP1 Q9P0U3 4/20 0.46
▸ SUMO2 P61956 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23787674 0.92 PHLPP2 (0.49) CYP1A2THRBAPPMAPTSNCA
SCHEMBL23787537 0.88 MPL (0.52) CYP1A2THRBAPPMAPTSNCA
SCHEMBL23787565 0.86 ALDH1A1 (0.67) THRBAPPMAPTSNCAHPGD
SCHEMBL23787780 0.85 PHLPP2 (0.67) CYP1A2THRBAPPMAPTSNCA
SCHEMBL23787724 0.82 CYP1A2 (0.54) CYP1A2THRBAPPMAPTSNCA
SCHEMBL23787782 0.82 CYP1A2 (0.54) CYP1A2THRBAPPMAPTSNCA
SCHEMBL23787551 0.82 PHLPP2 (0.54) CYP1A2THRBHPGDMEN1ALDH1A1
SCHEMBL23787781 0.81 SENP2 (0.58) CYP1A2THRBAPPMAPTSNCA
SCHEMBL23787721 0.81 PHLPP2 (0.72) CYP1A2THRBAPPMAPTSNCA
SCHEMBL23787723 0.81 APP (0.75) CYP1A2THRBAPPMAPTSNCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210275548-A1 NOVEL DNA POLYMERASE GAMMA INHIBITOR AND USES THEREOF ACIBADEM MEHMET ALI AYDINLAR UNIVERSITESI (TR) 2021-09-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210275548-A1 NOVEL DNA POLYMERASE GAMMA INHIBITOR AND USES THEREOF POLG, POLB, POLA1 CYP1A2 4524/4885THRB 2774/4885APP 3911/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback